Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Clinical Trial of Autologous Hematopoietic Stem Cell Gene Therapy in RAG1-Deficient Severe Combined Immunodeficiency

NCT04797260 is registered in ClinicalTrials.gov with Videja B.V. as lead sponsor.

NCT NCT04797260
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04797260 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Clinical Trial of Autologous Hematopoietic Stem Cell Gene Therapy in RAG1-Deficient Severe Combined Immunodeficiency
Lead sponsor
Videja B.V.
Phase
Phase 1/2
Overall status
Suspended
Start date
July 23, 2021
Completion date
December 31, 2031
Enrollment
10 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

severe combined immunodeficiency due to rag1 deficiency